Stephanie Karzon Abrams

Talk Title
Psychedelics for the Contemporary Soul: Reclaiming Connection through Ancient Wisdom and Modern Medicine
Talk Description
In "Psychedelics for the Contemporary Soul: Reclaiming Connection through Ancient Wisdom and Modern Medicine", Stephanie delves into the transformative power of psychedelic substances and legal plant medicines, bridging ancient traditions with contemporary practices. This talk explores the neurochemistry behind these tools and the broader neurochemistry of connection, highlighting how they can foster deep personal and communal connections and enhance mental well-being. By integrating historical rituals, cutting-edge science, and cultural insights, the presentation provides a comprehensive educational experience that illuminates how these practices can heal and enrich our increasingly disconnected world.

‍
Speaker Biography
Stephanie Karzon Abrams, a neuropharmacologist with a Masters of Science in Clinical Pharmacology, is the founding advisor of Beyond Consulting. The firm provides science, research, operations, and strategy solutions to organizations and clinics in the natural product, plant medicine, and psychedelic sectors. A recognized leader in shaping the future of integrative and innovative healthcare, Stephanie Karzon Abrams champions the exploration of novel therapeutic approaches. Her interests extend beyond neurology, encompassing plant medicines, women's health, and the potential of music to enhance healing.

Stephanie is a dedicated advocate for public education and strives to redefine the landscape of health and wellness through open access education and public speaking. Her passions extend to community building, philanthropy, and music, with a particular focus on integrating her passions through unique gatherings and initiatives that foster connection. Stephanie is co-creator of Public Secret, a music label, management agency, and artist collective; Mt. Mushmore, Higher Elevation, a social and educational dinner series; and The Last 6, a community organization that educates and funds research for the acute childhood illness, Kawasaki disease.

Stephanie’s career path transcends traditional boundaries, blending her deep scientific expertise with strategic thinking and a passion for exploring innovative healthcare solutions. Her foundation lies in rigorous research, followed by experience at Johnson and Johnson (Biosense Webster) where she honed her operational, strategic planning, and key opinion leader (KOL) engagement skills. Stephanie’s current work as a prescriber for MDMA and psilocybin therapy for the Canadian Special Access Program (SAP), and her role as a scientific advisor for the Microdosing Collective, exemplifies her commitment to advancing these emerging fields.